Advanced Glycation-Modified Human Serum Albumin Evokes Alterations in Membrane and Eryptosis in Erythrocytes

Applied Biochemistry and Biotechnology

Volumn 177, Issue 5, 2015, Pages 1013-1024

  Awasthi, Saurabh ^a   Gayathiri, S K ^a   Ramya, R ^a   Duraichelvan, R ^b   Dhason, A ^b   Saraswathi, N T ^a  

^a SASTRA UNIVERSITY   (India)

^b RAMAN RESEARCH INSTITUTE   (India)

Author keywords

Advanced glycation end products; Albumin; Arg pyrimidine; Carboxyethyllysine; Carboxymethyllysine; Eryptosis; Erythrocytes

Indexed keywords

AROMATIC COMPOUNDS; CELL MEMBRANES; CELLS; CYTOLOGY; GLYCOSYLATION; OXIDANTS;

ADVANCED GLYCATION END PRODUCTS; ALBUMIN; ARG-PYRIMIDINE; CARBOXYETHYLLYSINE; CARBOXYMETHYLLYSINE; ERYPTOSIS; ERYTHROCYTES;

BLOOD;

6 N CARBOXYMETHYLLYSINE; ADVANCED GLYCATION END PRODUCT; ALBUMIN; ARGININE; ARGPYRIMIDINE; CARBOXYETHYLLYSINE; GLYOXYLIC ACID; HUMAN SERUM ALBUMIN; METHYLGLYOXAL; PHENANTHRENEQUINONE; PYRUVIC ACID; TRINITROBENZENESULFONIC ACID; UNCLASSIFIED DRUG; SERUM ALBUMIN;

ADVANCED GLYCATION; ARTICLE; BIOACCUMULATION; BLOOD CELL; CELL DAMAGE; CELL INTERACTION; CELL MEMBRANE; CELL STRUCTURE; COMPARATIVE STUDY; DIABETES MELLITUS; ERYPTOSIS; ERYTHROCYTE; ERYTHROCYTE STRUCTURE; FIELD EMISSION SCANNING ELECTRON MICROSCOPY; GLYCATION; HUMAN; IN VIVO STUDY; OXIDATIVE STRESS; ADULT; CHEMISTRY; ERYTHROCYTE MEMBRANE; MALE; METABOLISM;

ADULT; ERYTHROCYTE MEMBRANE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; MALE; SERUM ALBUMIN;

EID: 84946495052     PISSN: 02732289     EISSN: 15590291     Source Type: Journal    
DOI: 10.1007/s12010-015-1793-x     Document Type: Article

References (42)

1. Vlassara, H., & Uribarri, J. (2014). Advanced glycation end products (AGE) and diabetes: cause, effect, or both? Curr Diabetes Rep, 14, 453.
2. Bodiga, V. L., Eda, S. R., & Bodiga, S. (2014). Advanced glycation end products: role in pathology of diabetic cardiomyopathy. Heart Failure Reviews, 19, 49–63.
3. Bucala, R. (2014). Diabetes, aging, and their tissue complications. The Journal of Clinical Investigation, 124, 1887–1888.
4. Vlassara, H., & Striker, G. E. (2013). Advanced glycation endproducts in diabetes and diabetic complications. Endocrinology and Metabolism Clinics of North America, 42, 697–719.
5. Willett, T. L., Kandel, R., De Cross, J. N., Avery, N. C., & Grynpas, M. D. (2012). Enhanced levels of non-enzymatic glycation and pentosidine cross-linking in spontaneous osteoarthritis progression. Osteoarthritis and Cartilage, 20, 736–744.
6. Aronson, D. (2003). Cross-linking of glycated collagen in the pathogenesis of arterial and myocardial stiffening of aging and diabetes. Journal of Hypertension, 21(1), 3–12.
7. Frye, E. B., Degenhardt, T. P., Thorpe, S. R., & Baynes, J. W. (1998). Role of the Maillard reaction in aging of tissue proteins. Advanced glycation end product-dependent increase in imidazolium cross-links in human lens proteins. The Journal of Biological Chemistry, 273(30), 18714–18719.
8. Hohn, A., Jung, T., & Grune, T. (2014). Pathophysiological importance of aggregated damaged proteins. Free Radical Biology & Medicine, 71, 70–89.
9. Guerreo, E., Vasudevaraju, P., Hegde, M. L., Britton, G. B., & Rao, K. S. (2013). Recent advances in α-synuclein functions, advanced glycation, and toxicity: implications for Parkinson's disease. Molecular Neurobiology, 47(2), 525–536.
10. Moreau, K. L., & King, J. A. (2012). Protein misfolding and aggregation in cataract disease and prospects for prevention. Trends in Molecular Medicine, 18(5), 273–282.
11. Nowotny, K., Jung, T., & Hohn, A. (2014). Accumulation of modified proteins and aggregate formation in aging. Experimental Gerontology, 57, 122–131.
12. Ikeda, K., Higashi, T., Sano, H., Jinnouchi, Y., Yoshida, M., Araki, T., & Horiuchi, S. (1996). N (epsilon)-(carboxymethyl)lysine protein adduct is a major immunological epitope in proteins modified with advanced glycation end products of the Maillard reaction. Biochemistry, 35, 8075–8083.
13. Reddy, S., Bichler, J., Wells-Knecht, K. J., Thorpe, S. R., & Baynes, J. W. (1995). N epsilon-(carboxymethyl)lysine is a dominant advanced glycation end product (AGE) antigen in tissue proteins. Biochemistry, 34, 10872–10878.
14. Rabbani, N., & Thornalley, P. J. (2014). The critical role of methylglyoxal and glyoxalase 1 in diabetic nephropathy. Diabetes, 63, 50–52.
15. Turkseven, S., Ertuna, E., Yetik-Anacak, G., & Yasa, M. (2013). Methylglyoxal causes endothelial dysfunction: the role of endothelial nitric oxide synthase and AMP-activated protein kinase alpha. Journal of Basic and Clinical Physiology and Pharmacology, 14, 1–7.
16. Vlassopoulos, A., Lean, M. E., & Combet, E. (2013). Role of oxidative stress in physiological albumin glycation: a neglected interaction. Free Radical Biology & Medicine, 60, 318–324.
17. Reddy, V. P., Zhu, X., Perry, G., & Smith, M. A. (2009). Oxidative stress in diabetes and Alzheimer’s disease. Journal of Alzheimer’s disease, 16(4), 763–774.
18. Li, H., Horke, S., & Forstermann, U. (2013). Oxidative stress in vascular disease and its pharmacological prevention. Trends in Pharmacological Sciences, 34(6), 313–319.
19. Schaffer, S. W., Jong, C. J., & Mozaffari, M. (2012). Role of oxidative stress in diabetes-mediated vascular dysfunction: unifying hypothesis of diabetes revisited. Vascular Pharmacology, 57(5–6), 139–149.
20. Huebschmann, A. G., Regensteiner, J. G., Vlassara, H., & Reusch, J. E. (2006). Diabetes and advanced glycoxidation end products. Diabetes Care, 29(6), 1420–1432.
21. Cohen, M. P., & Ziyadeh, F. N. (1996). Role of Amadori-modified nonenzymatically glycated serum proteins in the pathogenesis of diabetic nephropathy. Journal of the American Society of Nephrology, 7, 183–190.
22. Kim, M. R., Yu, S. A., Kim, M. Y., Choi, K., & Kim, C. W. (2014). Analysis of glycated serum proteins in type 2 diabetes patients with nephropathy. Biotechnolo Bioprocs Eng, 19, 83–92.
23. Stirban, A., Gawlowski, T., & Roden, M. (2014). Vascular effects of advanced glycation endproducts: clinical effects and molecular mechanisms. Mol Metab, 3, 94–108.
24. Kamruzzahan, A. S., Kienberger, F., Stroh, C. M., Berg, J., Huss, R., Ebner, A., & Hinterdorfer, P. (2004). Imaging morphological details and pathological differences of red blood cells using tapping-mode AFM. Biological Chemistry, 385, 955–960.
25. Umudum, F., Yucel, O., Sahin, Y., & Bakan, E. (2002). Erythrocyte membrane glycation and NA(+)-K(+) levels in NIDDM. J Diabetes Complication, 16, 359–362.
26. Pretorius, E. (2013). The adaptability of red blood cells. Cardiovascular Diabetology, 12, 1475–2840.
27. Ahmed, N., Argirov, O. K., Minhas, H. S., Cordeiro, C. A., & Thornalley, P. J. (2002). Assay of advanced glycation endproducts (AGEs): surveying AGEs by chromatographic assay with derivatization by 6-aminoquinolyl-N-hydroxysuccinimidyl-carbamate and application to Nepsilon-carboxymethyl-lysine- and Nepsilon-(1-carboxyethyl)lysine-modified albumin. The Biochemical Journal, 364, 1–14.
28. Laemmli, U. K. (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 227, 680–685.
29. Cayot, P., & Tainturier, G. (1997). The quantification of protein amino groups by the trinitrobenzenesulfonic acid method: a reexamination. Analytical Biochemistry, 249, 184–200.
30. Smith, R. E., & MacQuarrie, (1978). A sensitive fluorometric method for the determination of arginine using 9,10-phenanthrenequinone. Analytical Biochemistry, 90, 246–255.
31. Manacelli, F., Storace, D., D’Arrigo, C., Sanguineti, R., Pacini, D., Furfaro, A. L., Pronzato, M. A., Odetti, P., & Traverso, N. (2013). Structural alterations of humans serum albumin caused by glycation and oxidative stressors revealed by circular dichroism analysis. International Journal of Molecular Sciences, 14(6), 10694–10709.
32. Kim, J., Kim, O. S., Kim, C. S., Sohn, E., Jo, K., & Kim, J. S. (2012). Accumulation of argpyrimidine, a methylglyoxal-derived advanced glycation end product, increases apoptosis of lens epithelial cells both in vitro and in vivo. Experimental & Molecular Medicine, 44, 167–175.
33. Gomes, R., Sousa Silva, M. S., Quintas, A., Cordeiro, C., Freire, A., Pereira, P., Martins, A., Monteiro, E., Barroso, E., & Freire, P. A. (2005). Argpyrimidine, a methylglyoxal-derived advanced glycation end-product in familial amyloidotic polyneuropathy. The Biochemical Journal, 15, 339–345.
34. Heine, G. H., Sester, U., Girndt, M., & Kohler, H. (2004). Acanthocytes in the urine: useful tool to differentiate diabetic nephropathy from glomerulonephritis? Diabetes Care, 27, 190–194.
35. Babu, N., & Singh, M. (2004). Influence of hyperglycemia on aggregation, deformability and shape parameters of erythrocytes. Clinical Hemorheology and Microcirculation, 31, 273–280.
36. Ciccoli, L., De Felice, C., Paccagnini, E., Leoncini, S., Pecorelli, A., Signorini, C., & Hayek, J. (2012). Morphological changes and oxidative damage in Rett syndrome erythrocytes. Biochimica et Biophysica Acta, 4, 511–520.
37. Malorni, W., Straface, E., Pagano, G., Monti, D., Zatterale, A., Del Principe, D., & Korkina, L. G. (2000). Cytoskeleton alterations of erythrocytes from patients with Fanconi’s anemia. FEBS Letters, 468, 125–128.
38. Somjee, S. S., Warrier, R. P., Thomson, J. L., Ory-Ascani, J., & Hempe, J. M. (2005). Advanced glycation end-products in sickle cell anaemia. British Journal of Haematology, 128, 112–118.
39. Mohanty, J. G., Shukla, H. D., Williamson, J. D., Launer, L. J., Saxena, S., & Rifkind, J. M. (2010). Alterations in the red blood cell membrane proteome in Alzheimer's subjects reflect disease-related changes and provide insight into altered cell morphology. Proteome Science, 8, 11.
40. Bourdon, E., Loreau, N., & Blache, D. (1999). Glucose and free radicals impairs the antioxidant properties of serum albumin. The FASEB Journal, 13(2), 233–244.
41. ε-(carboxyethyl)lysine in type 1 diabetic patients with impaired renal function: correlation with markers of endothelial dysfunction. Nephrology, Dialysis, Transplantation, 19, 631–636.
42. Pisani, A., Diomedi, M., Cianciulli, P., Floris, R., Orlacchio, A., Bernardi, G., & Calabresi, P. (2005). Acanthocytes as a predisposing factor for non-ketotic hyperglycaemia induced chorea-ballism. Journal of Neurology, Neurosurgery, and Psychiatry, 76(12), 1717–1719.